NYSE:MDHealthcare
A Look At Pediatrix Medical Group (MD) Valuation After Q1 Update And Raised Analyst Outlook
Pediatrix Medical Group (MD) is back in focus after its latest Q1 update, where management reported improved profitability, stronger cash collections, reaffirmed 2026 EBITDA guidance, and highlighted continued growth in core neonatal and maternal-fetal care services.
See our latest analysis for Pediatrix Medical Group.
At a share price of US$23.01, Pediatrix Medical Group has a 1-year total shareholder return of 51.78% and a 3-year total shareholder return of 70.07%, while the 5-year total...